Jul 23, 2021: In the course of reviewing the last 12 months of ergoloid samples for the possible presence of tryptamine (see LSD sample #10683 for context), in this sample #10500 the lab identified the presence of tri-ethyl citrate, which was not originally reported when this result was first published in Jun 2021 (blotter, which often contains ink, can cause peaks that are not always reported). The GC/MS graph for the substance that was identified as tri-ethyl citrate is pictured, left.
Tri-ethyl citrate is not psychoactive, and its presence has no clear explanation. Perhaps it was included at some point in the solution of LSD as a protectant. This is speculative.
Send in a sample for testing
DrugsData tests all psychoactive drugs including ecstasy tablets, powders, research chemicals, novel pschoactive substances, and other drugs through our licensed laboratory. Ecstasy/Molly tablets cost $100. Recreational drug powder/crystal/blotter costs $100. Pharmaceuticals, supplements and all others cost $150 per analysis.
Should the public have access to independent analysis of the products they consume?
The vast majority of analyses of over-the-counter, prescription, and recreational drugs are performed in secret with no independent oversite or review. No other historical record, free from politically-controlled agencies, is currently available in North America nor most other parts of the world.
DrugsData, a project of Erowid Center, needs the support of professionals, students, parents, individuals with means, and small foundations for a total yearly budget of around $120,000 USD. Erowid Center's general budget and the co-pays we require fund most of this cost.
Tri-ethyl citrate is not psychoactive, and its presence has no clear explanation. Perhaps it was included at some point in the solution of LSD as a protectant. This is speculative.